Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000012913 | SCV000461949 | likely benign | Age related macular degeneration 14 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000304426 | SCV000461950 | likely benign | Complement component 2 deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Laboratory for Molecular Medicine, |
RCV000454375 | SCV000538519 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF |
Mendelics | RCV000304426 | SCV001137072 | benign | Complement component 2 deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001516299 | SCV001724564 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001516299 | SCV001882547 | benign | not provided | 2020-07-20 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 9670930, 22610944, 25525159, 32113979, 16936732, 16518403) |
Fulgent Genetics, |
RCV002496332 | SCV002806298 | likely benign | Complement component 2 deficiency; Age related macular degeneration 14 | 2022-04-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001516299 | SCV005225529 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000012913 | SCV000033154 | pathogenic | Age related macular degeneration 14 | 2006-09-01 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000454375 | SCV001739738 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000454375 | SCV001928698 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000454375 | SCV001957275 | benign | not specified | no assertion criteria provided | clinical testing |